3-(2-piperidinoethoxy)pyrrolidine | 70001-70-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 3-(2-piperidinoethoxy)pyrrolidine
• 英文别名: 1-[2-(Pyrrolidin-3-yloxy)ethyl]piperidine；1-(2-pyrrolidin-3-yloxyethyl)piperidine
• CAS: 70001-70-6
• 化学式: C₁₁H₂₂N₂O
• mdl: MFCD16709393
• 分子量: 198.308
• InChiKey: WXGLFUSDLRRYFE-UHFFFAOYSA-N

物化性质

• 沸点：
  284.8±30.0 °C(Predicted)
• 密度：
  1.02±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(2-piperidinoethoxy)pyrrolidine 在 盐酸 、 caesium carbonate 、 N,N-二异丙基乙胺 作用下， 以 1,4-二氧六环 、 乙醇 、 水 为溶剂， 反应 1.08h， 生成 5-[4-[3-[2-(1-piperidyl)ethoxy]pyrrolidin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrimidine-2,4-diol
  参考文献：
  名称：

  [EN] CD73 INHIBITOR COMPOUNDS
  [FR] COMPOSÉS INHIBITEURS DE CD73

  摘要：

  The present invention relates to compounds of formula I shown below: wherein R1, X2, X3, X4, X5, X6, X7, X8and X9are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine CD73 activity is implicated, such as, for example, cancer.

  公开号：

  WO2023233130A1
• 作为产物：
  描述：

  benzyl 3-[2-(1-piperidyl)ethoxy]pyrrolidine-1-carboxylate 在 palladium 10% on activated carbon 作用下， 以 乙醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 生成 3-(2-piperidinoethoxy)pyrrolidine
  参考文献：
  名称：

  [EN] CD73 INHIBITOR COMPOUNDS
  [FR] COMPOSÉS INHIBITEURS DE CD73

  摘要：

  The present invention relates to compounds of formula I shown below: wherein R1, X2, X3, X4, X5, X6, X7, X8and X9are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine CD73 activity is implicated, such as, for example, cancer.

  公开号：

  WO2023233130A1

文献信息

• 1-Substituted-3-aminoethoxypyrrolidines
  申请人：A. H. Robins Company, Incorporated

  公开号：US04096331A1

  公开（公告）日：1978-06-20

  1-Substituted-3-aminoethoxypyrrolidines possessing hypotensive properties are disclosed. The compounds are prepared from 3-aminoethoxypyrrolidines.

  揭示了具有降压作用的1-取代-3-氨基乙氧吡咯烷。这些化合物是从3-氨基乙氧吡咯烷制备的。
• 1-Substituted-3-aminoethoxypyrrolidines and use thereof
  申请人：A. H. Robins Company, Inc.

  公开号：US04139620A1

  公开（公告）日：1979-02-13

  1-Substituted-3-aminoethoxypyrrolidines having the formula ##STR1## WHEREIN R is benzyl, 2-ethoxyphenoxylower-alkyl, 2-propionyloxy-ethyl, 2-methoxy-4-acetylphenoxylower-alkyl, 4-fluorophenoxy lower alkyl, benzoyloxylower-alkyl, 3,4,5-trimethoxybenzoyloxylower-alkyl, 3,4,5-trimethoxybenzoyl, N-(4-methoxyphenyl) carbamoyl, 2-methoxyphenoxylower-alkyl, 3,4,5-trimethoxyphenyl-acetyl, 2-piperidinoethyl or carbamoyl, and Am is dilower-alkylamino, morpholino or piperidino having hypotensive properties are disclosed.

  具有以下结构的1-取代-3-氨基乙氧吡咯烷类化合物的化学式为##STR1##其中R为苄基、2-乙氧基苯氧基较低烷基、2-丙酰氧乙基、2-甲氧基-4-乙酰苯氧基较低烷基、4-氟苯氧基较低烷基、苯甲酰氧较低烷基、3,4,5-三甲氧基苯甲酰氧较低烷基、3,4,5-三甲氧基苯甲酰、N-(4-甲氧基苯基)氨甲酰、2-甲氧基苯氧基较低烷基、3,4,5-三甲氧基苯乙酰、2-哌啶乙基或氨甲酰，以及Am为二低烷基氨基、吗啉基或哌啶基，具有降压作用。
• US4139620A
  申请人：——

  公开号：US4139620A

  公开（公告）日：1979-02-13
• US4096331A
  申请人：——

  公开号：US4096331A

  公开（公告）日：1978-06-20
• [EN] CD73 INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE CD73
  申请人：[en]ADORX THERAPEUTICS LIMITED

  公开号：WO2023233130A1

  公开（公告）日：2023-12-07

  The present invention relates to compounds of formula I shown below: wherein R1, X2, X3, X4, X5, X6, X7, X8and X9are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine CD73 activity is implicated, such as, for example, cancer.